PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22905230-4	2012	On one hand, we show that IP6 decreases the osteoclastogenesis in RAW 264.7 cells induced by RANKL, without affecting cell proliferation or cell viability.	Phytic Acid	26-29	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	93-98	
23221481-6	2012	Besides, Rankl mRNA levels were decreased after IP6 treatment in MC3T3-E1 cells, pointing to a paracrine effect on osteoclasts.	Phytic Acid	48-51	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	9-14	
22905230-5	2012	The number of TRAP positive cells and mRNA levels of osteoclast markers such as TRAP, calcitonin receptor, cathepsin K and MMP-9 was decreased by IP6 on RANKL-treated cells.	Phytic Acid	146-149	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	153-158	
22905230-6	2012	On the contrary, when giving IP6 to mature osteoclasts after RANKL treatment, a significant increase of bone resorption activity and TRAP mRNA levels was found.	Phytic Acid	29-32	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	61-66